GW 610

CAS No. 872726-44-8

GW 610 ( —— )

Catalog No. M27466 CAS No. 872726-44-8

GW 610 is an antitumor benzothiazole that shows growth-inhibitory activity against several cancer cell lines.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 35 Get Quote
5MG 58 Get Quote
10MG 87 Get Quote
25MG 205 Get Quote
50MG 335 Get Quote
100MG 537 Get Quote
500MG 1134 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    GW 610
  • Note
    Research use only, not for human use.
  • Brief Description
    GW 610 is an antitumor benzothiazole that shows growth-inhibitory activity against several cancer cell lines.
  • Description
    GW 610 is an antitumor benzothiazole that shows growth-inhibitory activity against several cancer cell lines. In MCF-7 and MDA 468 human cancer cell lines, potent antiproliferative activity (growth inhibition (GI50) < 0.1 nM) was observed.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    872726-44-8
  • Formula Weight
    289.3
  • Molecular Formula
    C15H12FNO2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc(ccc(-c1nc(cc(cc2)F)c2s1)c1)c1OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Pei Feng, et al. Phosphating process for steel pipe. CN110359036B
molnova catalog
related products
  • 2'-Deoxyadenosine 5'...

    Adenosine is a nucleoside comprised of adenine attached to a ribose (ribofuranose) moiety via a -N9-glycosidic bond. Deoxyadenosine monophosphate is a derivative of the common nucleic acid ATP or adenosine triphosphate in which the -OH (hydroxyl) group on the 2' carbon on the nucleotide's pentose has been removed (hence the deoxy- part of the name).

  • Exendin-3/4 (59-86)

    Exendin-3/4 (59-86) is a Exendin-4 peptide derivative.

  • HS271

    HS271 is a highly potent, orally active and selective IRAK4 inhibitor, with an IC50 of 7.2 μM. HS271 exhibits superior enzymatic and cellular activities, as well as excellent pharmacokinetic properties.